Fairvalue-Calculator Fairvalue-Calculator
EN DE

Pihlajalinna Oyj (PIHLIS) Fair Value & Analysis

Healthcare · FI · Market cap €242M

Price€10.34
Fair Value€32.69
Upside+216.2%
Quality95/100
Evidence: High Range €21.50 – €43.88

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Pihlajalinna Oyj (PIHLIS) currently trades at €10.34, while our model-based Fair Value estimate is €32.69 — implying the stock looks roughly 216.2% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Pihlajalinna Oyj provides social, healthcare, and wellbeing services to private persons, companies, insurance companies, and public sector entities in Finland. It operates in two segments, Private Healthcare Services and Public Services. The company offers general practitioner and medical specialist, occupational healthcare, social and healthcare outsourcing, fitness center, responsible doctor, and remote consultation services, as well as residential and staffing services. It also provides occupational health services to private clinics and hospitals, responsible doctor, diagnostics, and rehabilitation services. The company was founded in 2014 and is headquartered in Tampere, Finland.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Pihlajalinna Oyj (PIHLIS) undervalued?
As of Jun 25, 2026, our model estimates a fair value of €32.69 versus a price of €10.34 — about +216% (undervalued). Model-based estimate, not financial advice.
What is the fair value of PIHLIS?
Our 21-model fair value for Pihlajalinna Oyj is €32.69 (as of Jun 25, 2026), built from audited fundamentals. The current price is €10.34.
What is the quality score of PIHLIS?
Pihlajalinna Oyj has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.